authors
- Sridhar, Srikala S
- Mackenzie, Mary J
- Hotte, Sebastien
- Mukherjee, Som
- Murray, Nevin
- Tannock, Ian F
- Haider, Masoom A
- Chen, Eric X
- Wang, Lisa
- Srinivasan, Ranuka
- Ivy, S Percy
- Moore, Malcolm J
AZD2171 (Cediranib) is active in first line metastatic renal cell carcinoma (RCC): Interim results of a phase II trial. A trial of the PMH Phase II Consortium
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- December 1, 2007
has subject area
- 1112 Oncology and Carcinogenesis (FoR)
- 1115 Pharmacology and Pharmaceutical Sciences (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Molecular Cancer Therapeutics Journal